Cynosure Group’s Cognizant CTSH Stock Holding History

Cynosure Group’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,870	Closed	-$329K	–	31
2022 Q2	$329K	Buy	+4,870	New	+$373K	0.32%	32

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cynosure Group's CTSH Position: Q3 2022 in Review

Cynosure Group sold out of Cognizant (CTSH) in Q3 2022, closing a stake of 4,870 shares — an estimated $329K sold.

Cynosure Group first reported a position in CTSH in Q2 2022 and held it in 1 quarter. The position peaked at $329K in Q2 2022. 888 funds tracked by Wall St. Rank hold CTSH as of Q3 2022.

Cynosure Group reported no remaining Cognizant position as of Q3 2022 after selling out during the quarter.
Cynosure Group sold 4,870 Cognizant shares in Q3 2022, an estimated $329K.
Cynosure Group first reported a position in Cognizant in Q2 2022 and held it in 1 quarter.
Cynosure Group's Cognizant position peaked at $329K in Q2 2022.
888 funds tracked by Wall St. Rank held Cognizant as of Q3 2022.

Based on Cynosure Group's 13F filing for Q3 2022, filed 14 Nov 2022.